Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1992 Apr;105(4):941–946. doi: 10.1111/j.1476-5381.1992.tb09082.x

Effects of monoamine uptake inhibitors on extracellular and platelet 5-hydroxytryptamine in rat blood: different effects of clomipramine and fluoxetine.

J Ortiz 1, F Artigas 1
PMCID: PMC1908726  PMID: 1387022

Abstract

1. The concentration of 5-hydroxytryptamine (5-HT) in rat platelet-free plasma increased significantly 30 min after a single i.p. injection (10 mg kg-1) of each of six inhibitors of the high-affinity 5-HT uptake (fluvoxamine, fluoxetine, alaproclate, paroxetine, sertraline and clomipramine). The increases ranged from 226% to 776% of control values. In contrast, imipramine, desipramine and femoxetine had no significant effect. The increase elicited by paroxetine was dependent on the dose (1, 5 and 10 mg kg-1) and returned to control values after 4 h. That observed after clomipramine was also transient and paralleled the plasma concentration of the drug (Spearman-rank correlation r = 0.43). 2. In vivo, the rat pulmonary vascular endothelium removed trace amounts (8.8 nmol in a bolus) of intravenously injected [14C]-5-HT. Paroxetine pretreatment (10 mg kg-1, 30 min before-hand) reduced this uptake by 73%. 3. Repeated fluoxetine treatments reduced rat whole blood 5-HT concentration (ca. -60% after daily 2 x 5 mg kg-1, i.p. during 14 days). However, plasma (extracellular) 5-HT was not increased. 4. Various repeated treatments with clomipramine (i.p. injections or osmotic minipumps, up to 30 mg kg-1 day-1), failed to decrease rat whole blood 5-HT concentrations. Platelet-free plasma 5-HT was also unchanged, even after treatments yielding plasma clomipramine levels 2.7 times higher than those that increased it acutely. 5. These results indicate that the extracellular pool of 5-HT in rat blood (measured in the platelet-free plasma) is physiologically under the control of high-affinity 5-HT uptake systems.(ABSTRACT TRUNCATED AT 250 WORDS)

Full text

PDF
941

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adell A., Artigas F. Differential effects of clomipramine given locally or systemically on extracellular 5-hydroxytryptamine in raphe nuclei and frontal cortex. An in vivo brain microdialysis study. Naunyn Schmiedebergs Arch Pharmacol. 1991 Mar;343(3):237–244. doi: 10.1007/BF00251121. [DOI] [PubMed] [Google Scholar]
  2. Adell A., Carceller A., Artigas F. Regional distribution of extracellular 5-hydroxytryptamine and 5-hydroxyindoleacetic acid in the brain of freely moving rats. J Neurochem. 1991 Feb;56(2):709–712. doi: 10.1111/j.1471-4159.1991.tb08208.x. [DOI] [PubMed] [Google Scholar]
  3. Anderson G. M., Feibel F. C., Cohen D. J. Determination of serotonin in whole blood, platelet-rich plasma, platelet-poor plasma and plasma ultrafiltrate. Life Sci. 1987 Mar 16;40(11):1063–1070. doi: 10.1016/0024-3205(87)90568-6. [DOI] [PubMed] [Google Scholar]
  4. Artigas F., Sarrias M. J., Martínez E., Gelpí E., Alvarez E., Udina C. Increased plasma free serotonin but unchanged platelet serotonin in bipolar patients treated chronically with lithium. Psychopharmacology (Berl) 1989;99(3):328–332. doi: 10.1007/BF00445552. [DOI] [PubMed] [Google Scholar]
  5. Artigas F., Sarrias M. J., Martínez E., Gelpí E. Serotonin in body fluids: characterization of human plasmatic and cerebrospinal fluid pools by means of a new HPLC method. Life Sci. 1985 Aug 5;37(5):441–447. doi: 10.1016/0024-3205(85)90406-0. [DOI] [PubMed] [Google Scholar]
  6. Auerbach S. B., Minzenberg M. J., Wilkinson L. O. Extracellular serotonin and 5-hydroxyindoleacetic acid in hypothalamus of the unanesthetized rat measured by in vivo dialysis coupled to high-performance liquid chromatography with electrochemical detection: dialysate serotonin reflects neuronal release. Brain Res. 1989 Oct 16;499(2):281–290. doi: 10.1016/0006-8993(89)90776-2. [DOI] [PubMed] [Google Scholar]
  7. Bosin T. R., Lahr P. D. Mechanisms influencing the disposition of serotonin in mouse lung. Biochem Pharmacol. 1981 Dec 1;30(23):3187–3193. doi: 10.1016/0006-2952(81)90517-7. [DOI] [PubMed] [Google Scholar]
  8. Caccia S., Cappi M., Fracasso C., Garattini S. Influence of dose and route of administration on the kinetics of fluoxetine and its metabolite norfluoxetine in the rat. Psychopharmacology (Berl) 1990;100(4):509–514. doi: 10.1007/BF02244004. [DOI] [PubMed] [Google Scholar]
  9. Carboni E., Di Chiara G. Serotonin release estimated by transcortical dialysis in freely-moving rats. Neuroscience. 1989;32(3):637–645. doi: 10.1016/0306-4522(89)90285-6. [DOI] [PubMed] [Google Scholar]
  10. Catravas J. D., Gillis C. N. Pulmonary clearance of [14C]-5-hydroxytryptamine and [3H]norepinephrine in vivo: effects of pretreatment with imipramine or cocaine. J Pharmacol Exp Ther. 1980 Apr;213(1):120–127. [PubMed] [Google Scholar]
  11. Celada P., Sarrias M. J., Artigas F. Serotonin and 5-hydroxyindoleacetic acid in plasma. Potential use as peripheral measures of MAO-A activity. J Neural Transm Suppl. 1990;32:149–154. doi: 10.1007/978-3-7091-9113-2_21. [DOI] [PubMed] [Google Scholar]
  12. Cook E. H., Jr, Leventhal B. L., Freedman D. X. Free serotonin in plasma: autistic children and their first-degree relatives. Biol Psychiatry. 1988 Aug;24(4):488–491. doi: 10.1016/0006-3223(88)90192-8. [DOI] [PubMed] [Google Scholar]
  13. Delgado P. L., Charney D. S., Price L. H., Aghajanian G. K., Landis H., Heninger G. R. Serotonin function and the mechanism of antidepressant action. Reversal of antidepressant-induced remission by rapid depletion of plasma tryptophan. Arch Gen Psychiatry. 1990 May;47(5):411–418. doi: 10.1001/archpsyc.1990.01810170011002. [DOI] [PubMed] [Google Scholar]
  14. Friedman E., Cooper T. B. Pharmacokinetics of chlorimipramine and its demethylated metabolite in blood and brain regions of rats treated acutely and chronically with chlorimipramine. J Pharmacol Exp Ther. 1983 May;225(2):387–390. [PubMed] [Google Scholar]
  15. Fuller R. W., Perry K. W., Molloy B. B. Effect of an uptake inhibitor on serotonin metabolism in rat brain: studies with 3-(p-trifluoromethylphenoxy)-N-methyl-3-phenylpropylamine (Lilly 110140). Life Sci. 1974 Sep 15;15(6):1161–1171. doi: 10.1016/s0024-3205(74)80012-3. [DOI] [PubMed] [Google Scholar]
  16. Greenshaw A. J. Osmotic mini-pumps: a convenient program for weight-adjusted filling concentrations. Brain Res Bull. 1986 May;16(5):759–761. doi: 10.1016/0361-9230(86)90150-4. [DOI] [PubMed] [Google Scholar]
  17. Kalén P., Strecker R. E., Rosengren E., Björklund A. Endogenous release of neuronal serotonin and 5-hydroxyindoleacetic acid in the caudate-putamen of the rat as revealed by intracerebral dialysis coupled to high-performance liquid chromatography with fluorimetric detection. J Neurochem. 1988 Nov;51(5):1422–1435. doi: 10.1111/j.1471-4159.1988.tb01107.x. [DOI] [PubMed] [Google Scholar]
  18. Lagerström P. O., Marle I., Persson B. A. Solvent extraction of tricyclic amines from blood plasma and liquid chromatographic determination. J Chromatogr. 1983 Mar 11;273(1):151–160. doi: 10.1016/s0378-4347(00)80931-7. [DOI] [PubMed] [Google Scholar]
  19. Lee S. L., Fanburg B. L. Serotonin uptake by bovine pulmonary artery endothelial cells in culture. I. Characterization. Am J Physiol. 1986 May;250(5 Pt 1):C761–C765. doi: 10.1152/ajpcell.1986.250.5.C761. [DOI] [PubMed] [Google Scholar]
  20. Martínez E., Artigas F., Suñol C., Tusell J. M., Gelpí E. Liquid-chromatographic determination of indole-3-acetic acid and 5-hydroxyindole-3-acetic acid in human plasma. Clin Chem. 1983 Jul;29(7):1354–1357. [PubMed] [Google Scholar]
  21. Mellerup E. T., Plenge P. Chlorimipramine--but not imipramine--rapidly reduces [3H]imipramine binding in human platelet membranes. Eur J Pharmacol. 1986 Jul 15;126(1-2):155–158. doi: 10.1016/0014-2999(86)90753-3. [DOI] [PubMed] [Google Scholar]
  22. Ortiz J., Artigas F., Gelpí E. Serotonergic status in human blood. Life Sci. 1988;43(12):983–990. doi: 10.1016/0024-3205(88)90543-7. [DOI] [PubMed] [Google Scholar]
  23. Ortiz J., Celada P., Martínez E., Artigas F. Plasma free 5HT, plasma 5HIAA and whole blood 5HT in the rat. Adv Exp Med Biol. 1991;294:447–450. doi: 10.1007/978-1-4684-5952-4_41. [DOI] [PubMed] [Google Scholar]
  24. Ortiz J., Mocaër E., Artigas F. Effects of the antidepressant drug tianeptine on plasma and platelet serotonin concentrations in the rat. Eur J Pharmacol. 1991 Jul 9;199(3):335–339. doi: 10.1016/0014-2999(91)90497-e. [DOI] [PubMed] [Google Scholar]
  25. Poirier M. F., Galzin A. M., Loo H., Pimoule C., Segonzac A., Benkelfat C., Sechter D., Zarifian E., Schoemaker H., Langer S. Z. Changes in [3H]5-HT uptake and [3H]imipramine binding in platelets after chlorimipramine in healthy volunteers. Comparison with maprotiline and amineptine. Biol Psychiatry. 1987 Mar;22(3):287–302. doi: 10.1016/0006-3223(87)90147-8. [DOI] [PubMed] [Google Scholar]
  26. Poirier M. F., Loo H., Benkelfat C., Sechter D., Zarifian E., Galzin A. M., Schoemaker H., Segonzac A., Langer S. Z. [3H]Imipramine binding and [3H]5HT uptake in human blood platelets: changes after one week chlorimipramine treatment. Eur J Pharmacol. 1984 Nov 27;106(3):629–633. doi: 10.1016/0014-2999(84)90069-4. [DOI] [PubMed] [Google Scholar]
  27. Robinson-White A., Peterson S., Hechtman H. B., Shepro D. Serotonin uptake by isolated adipose capillary endothelium. J Pharmacol Exp Ther. 1981 Jan;216(1):125–128. [PubMed] [Google Scholar]
  28. Sarkissian C. F., Wurtman R. J., Morse A. N., Gleason R. Effects of fluoxetine or D-fenfluramine on serotonin release from, and levels in, rat frontal cortex. Brain Res. 1990 Oct 8;529(1-2):294–301. doi: 10.1016/0006-8993(90)90840-8. [DOI] [PubMed] [Google Scholar]
  29. Sarrias M. J., Artigas F., Martínez E., Gelpí E., Alvarez E., Udina C., Casas M. Decreased plasma serotonin in melancholic patients: a study with clomipramine. Biol Psychiatry. 1987 Dec;22(12):1429–1438. doi: 10.1016/0006-3223(87)90100-4. [DOI] [PubMed] [Google Scholar]
  30. Shopsin B., Friedman E., Gershon S. Parachlorophenylalanine reversal of tranylcypromine effects in depressed patients. Arch Gen Psychiatry. 1976 Jul;33(7):811–819. doi: 10.1001/archpsyc.1976.01770070041003. [DOI] [PubMed] [Google Scholar]
  31. Shopsin B., Gershon S., Goldstein M., Friedman E., Wilk S. Use of synthesis inhibitors in defining a role for biogenic amines during imipramine treatment in depressed patients. Psychopharmacol Commun. 1975;1(2):239–249. [PubMed] [Google Scholar]
  32. Steinberg H., Das D. K. Competition between platelets and lung for 5-hydroxytryptamine uptake. Exp Lung Res. 1980 Jun;1(2):121–130. doi: 10.3109/01902148009069642. [DOI] [PubMed] [Google Scholar]
  33. Wiersma D. A., Roth R. A. Clearance of 5-hydroxytryptamine by rat lung and liver: the importance of relative perfusion and intrinsic clearance. J Pharmacol Exp Ther. 1980 Jan;212(1):97–102. [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES